tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CHRO

Genentech announces lidERA Breast Cancer study meets primary endpoint
The FlyGenentech announces lidERA Breast Cancer study meets primary endpoint
24m ago
CHRO
Midday Fly By: AMD sees acceleration, IBM unveils quantum processor
PremiumThe Fly
Midday Fly By: AMD sees acceleration, IBM unveils quantum processor
6d ago
C
T
Pharma firms spending billions on treatments based off old drugs, Bloomberg says
PremiumThe Fly
Pharma firms spending billions on treatments based off old drugs, Bloomberg says
6d ago
BMY
MRK
FDA appoints Richard Pazdur as Director of CDER
PremiumThe Fly
FDA appoints Richard Pazdur as Director of CDER
7d ago
AZN
BMY
Roche upgraded to Hold from Sell at Deutsche Bank
PremiumThe Fly
Roche upgraded to Hold from Sell at Deutsche Bank
7d ago
CHRO
Genentech reports first relapsing multiple sclerosis trial met primary endpoint
PremiumThe FlyGenentech reports first relapsing multiple sclerosis trial met primary endpoint
8d ago
CHRO
Nokia Roche
Premium
The Fly
Nokia Roche
8d ago
NOK
CHRO
Nokia appoints Kristen Pressner as chief people officer
Premium
The Fly
Nokia appoints Kristen Pressner as chief people officer
8d ago
NOK
CHRO
Genentech reports ALLEGORY study meets primary endpoint, secondary endpoints
PremiumThe Fly
Genentech reports ALLEGORY study meets primary endpoint, secondary endpoints
15d ago
CHRO
FDA moves to accelerate biosimilar development, lower drug costs
PremiumThe Fly
FDA moves to accelerate biosimilar development, lower drug costs
19d ago
AZN
BMY
Roche price target raised to CHF 255 from CHF 245 at Morgan Stanley
PremiumThe Fly
Roche price target raised to CHF 255 from CHF 245 at Morgan Stanley
20d ago
CHRO
Roche receives CE mark for Elecsys Dengue Ag test
PremiumThe Fly
Roche receives CE mark for Elecsys Dengue Ag test
20d ago
CHRO
Genentech announces INShore study of Gazyva meets primary endpoint
PremiumThe FlyGenentech announces INShore study of Gazyva meets primary endpoint
21d ago
CHRO
Roche assumed with an Underperform at Jefferies
Premium
The Fly
Roche assumed with an Underperform at Jefferies
22d ago
CHRO
Rapt Therapeutics initiated with a Buy at Guggenheim
Premium
The Fly
Rapt Therapeutics initiated with a Buy at Guggenheim
22d ago
CHRO
RAPT
Labcorp to offer Elecsys pTau181 test for Alzheimer’s disease
PremiumThe Fly
Labcorp to offer Elecsys pTau181 test for Alzheimer’s disease
26d ago
LH
Roche reports 9 month group sales CHF 45.86B vs CHF 44.984B last year
PremiumThe Fly
Roche reports 9 month group sales CHF 45.86B vs CHF 44.984B last year
26d ago
CHRO
Roche sees FY25 core EPS growing in high single digit range
PremiumThe Fly
Roche sees FY25 core EPS growing in high single digit range
26d ago
CHRO
Trump Trade: Trump administration prepares new probe into pharma prices
PremiumThe Fly
Trump Trade: Trump administration prepares new probe into pharma prices
27d ago
CI
AZN
Trump admin prepares new probe into U.S. pharma prices, FT says
PremiumThe FlyTrump admin prepares new probe into U.S. pharma prices, FT says
27d ago
CI
AZN
Celcuity price target raised to $95 from $70 at Needham
Premium
The Fly
Celcuity price target raised to $95 from $70 at Needham
29d ago
CELC
CHRO
Oppenheimer remains bullish on Olema despite ‘Jekyll and Hyde kinda ESMO’
Premium
The Fly
Oppenheimer remains bullish on Olema despite ‘Jekyll and Hyde kinda ESMO’
29d ago
CHRO
OLMA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >